Jan-11-21 Downgrade
Oppenheimer
Outperform → Perform
Dec-18-20 Initiated
Stephens
Overweight
$31
Sep-17-20 Initiated
Truist
Buy
$24
Oct-09-19 Initiated
H.C. Wainwright
Buy
$19
Feb-28-19 Downgrade
Needham
Buy → Hold
Aug-08-18 Reiterated
Needham
Buy
$15 → $14
Jul-16-18 Upgrade
Ladenburg Thalmann
Neutral → Buy
Apr-04-18 Initiated
Leerink Partners
Outperform
$15
Mar-06-18 Reiterated
Needham
Buy
$5 → $15
Mar-06-18 Downgrade
Ladenburg Thalmann
Buy → Neutral
Mar-05-18 Reiterated
BTIG Research
Buy
$8 → $13
Jun-21-17 Initiated
BTIG Research
Buy
$6
Mar-13-17 Reiterated
Needham
Buy
$9 → $6
Dec-22-16 Initiated
Piper Jaffray
Overweight
$6
Nov-09-16 Reiterated
Needham
Buy
$12 → $9
Apr-05-16 Downgrade
BofA/Merrill
Buy → Neutral
Mar-11-16 Upgrade
Needham
Hold → Buy
$12
Apr-09-21 09:24AM
Mar-18-21 05:40PM
08:16AM
Mar-17-21 06:00PM
Mar-10-21 05:50PM
08:30AM
Mar-08-21 07:43AM
Mar-04-21 06:33AM
Mar-02-21 08:30AM
Feb-24-21 02:01PM
08:50AM
08:00AM
06:30AM
Feb-22-21 08:30AM
Feb-16-21 08:30AM
Feb-12-21 08:30AM
Feb-10-21 08:00AM
Feb-04-21 12:00PM
Feb-01-21 09:42AM
05:20AM
Jan-25-21 08:30AM
Jan-11-21 07:15AM
Jan-08-21 08:30AM
Jan-07-21 08:30AM
07:05AM
Jan-06-21 12:48PM
Dec-19-20 10:10PM
Dec-18-20 08:30AM
Nov-09-20 11:44AM
Nov-05-20 10:32PM
08:00AM
Nov-03-20 09:43AM
05:54AM
Nov-02-20 08:30AM
06:40AM
Oct-30-20 03:54PM
Oct-29-20 11:30AM
11:24AM
Oct-22-20 08:30AM
Oct-14-20 08:00AM
Oct-12-20 10:35AM
Oct-09-20 08:30AM
Sep-16-20 07:30AM
07:30AM
Sep-09-20 08:30AM
Sep-04-20 08:30AM
Aug-25-20 08:25AM
07:00AM
Aug-10-20 09:19AM
Aug-05-20 08:00AM
Jul-22-20 08:30AM
Jul-15-20 08:33AM
Jul-09-20 08:30AM
Jun-30-20 07:00AM
07:00AM
Jun-23-20 01:48PM
May-28-20 03:38AM Thomson Reuters StreetEvents
May-27-20 11:14AM
May-26-20 09:27AM
May-13-20 08:30AM
May-06-20 12:02AM
May-05-20 09:34AM
08:00AM
Apr-22-20 08:30AM
Apr-10-20 09:00AM
Apr-08-20 08:30AM
Apr-02-20 02:58PM American City Business Journals
09:00AM
Mar-31-20 09:39AM
Mar-10-20 03:17AM Thomson Reuters StreetEvents
Mar-04-20 08:29AM
Mar-03-20 09:28AM
Feb-25-20 08:00AM
06:15AM
Feb-24-20 10:04AM
09:05AM
09:02AM
Feb-19-20 08:00AM
Feb-14-20 09:49AM
Feb-13-20 08:48AM
08:44AM
Feb-12-20 08:06AM
07:38AM
Feb-11-20 08:00AM
Feb-10-20 10:20AM
Jan-31-20 12:46PM
Jan-09-20 08:00AM
Jan-06-20 06:30AM
Dec-19-19 07:07AM
Dec-17-19 02:46PM
Dec-11-19 09:48AM
Dec-06-19 07:20AM Thomson Reuters StreetEvents
Nov-06-19 10:55AM
09:00AM
Nov-05-19 08:00AM
Oct-31-19 03:43PM
Oct-28-19 08:18PM
Oct-22-19 08:30AM
Oct-09-19 03:09PM
Oct-02-19 07:30AM
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Colangelo Dominick President and CEO Mar 30 Option Exercise 25.80 7,500 193,500 175,050 Mar 30 04:50 PM Hopper Jonathan Mark Chief Medical Officer Mar 30 Option Exercise 10.95 33,438 366,146 49,584 Mar 31 04:17 PM Hopper Jonathan Mark Chief Medical Officer Mar 30 Sale 51.40 17,924 921,270 22,966 Mar 31 04:17 PM Colangelo Dominick President and CEO Mar 29 Sale 51.01 40,000 2,040,254 167,550 Mar 30 04:50 PM Rubino Alan L Director Mar 19 Option Exercise 45.20 5,000 226,000 7,644 Mar 22 04:19 PM Colangelo Dominick President and CEO Mar 01 Option Exercise 3.80 28,355 107,696 243,742 Mar 02 04:15 PM Colangelo Dominick President and CEO Mar 01 Sale 48.11 40,000 1,924,227 207,550 Mar 02 04:15 PM Hopper Jonathan Mark Chief Medical Officer Feb 11 Option Exercise 0.00 1,625 0 25,371 Feb 12 04:17 PM Colangelo Dominick President and CEO Feb 11 Option Exercise 0.00 7,500 0 222,462 Feb 12 04:16 PM Halpin Michael Chief Operating Officer Feb 11 Option Exercise 0.00 3,500 0 6,953 Feb 12 04:12 PM Halpin Michael Chief Operating Officer Feb 06 Option Exercise 0.00 1,875 0 4,345 Feb 08 04:26 PM Hopper Jonathan Mark Chief Medical Officer Feb 06 Option Exercise 0.00 650 0 24,010 Feb 08 04:25 PM Colangelo Dominick President and CEO Feb 06 Option Exercise 0.00 6,938 0 218,040 Feb 08 04:24 PM Halpin Michael Chief Operating Officer Dec 21 Option Exercise 2.65 30,000 79,500 32,279 Dec 23 04:10 PM Hopper Jonathan Mark Chief Medical Officer Dec 21 Option Exercise 10.95 43,264 473,741 35,069 Dec 23 04:11 PM Hopper Jonathan Mark Chief Medical Officer Dec 21 Sale 26.54 24,235 643,159 4,331 Dec 23 04:11 PM Halpin Michael Chief Operating Officer Dec 21 Sale 26.28 30,000 788,400 2,279 Dec 23 04:10 PM ZERBE ROBERT L MD Director Nov 23 Option Exercise 3.25 30,000 97,500 49,295 Nov 24 04:09 PM ZERBE ROBERT L MD Director Nov 23 Sale 23.55 17,500 412,125 31,795 Nov 24 04:09 PM Halpin Michael Chief Operating Officer Jun 23 Option Exercise 7.20 14,751 106,207 16,373 Jun 24 04:19 PM Halpin Michael Chief Operating Officer Jun 23 Sale 15.01 14,751 221,413 1,622 Jun 24 04:19 PM Halpin Michael Chief Operating Officer Jun 16 Option Exercise 2.65 2,890 7,658 5,624 Jun 18 04:03 PM Halpin Michael Chief Operating Officer Jun 16 Sale 15.00 4,002 60,030 1,622 Jun 18 04:03 PM Colangelo Dominick President and CEO May 08 Option Exercise 2.75 13,125 36,094 210,492 May 08 04:09 PM ZERBE ROBERT L MD Director Apr 29 Option Exercise 0.00 1,750 0 19,295 May 01 04:17 PM GILMAN STEVEN C Director Apr 29 Option Exercise 0.00 1,750 0 1,750 May 01 04:15 PM Hagen Heidi Director Apr 29 Option Exercise 0.00 1,750 0 1,750 May 01 04:14 PM MCLAUGHLIN KEVIN F Director Apr 29 Option Exercise 0.00 1,750 0 1,750 May 01 04:13 PM Wotton Paul K Director Apr 29 Option Exercise 0.00 1,750 0 1,750 May 01 04:12 PM Rubino Alan L Director Apr 29 Option Exercise 0.00 1,750 0 2,644 May 01 04:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite